Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
about
British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxinConversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical PracticeEvaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data.Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products.
P2860
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
@ast
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
@en
type
label
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
@ast
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
@en
prefLabel
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
@ast
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
@en
P2093
P2860
P356
P1476
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm
@en
P2093
Andrew R Harrison
Juwan Park
Michael S Lee
P2860
P304
P356
10.2147/OPTH.S13978
P407
P577
2011-06-01T00:00:00Z